These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region. Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC mBio; 2020 Mar; 11(2):. PubMed ID: 32209677 [TBL] [Abstract][Full Text] [Related]
40. A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model. Kennedy EM; Dowall SD; Salguero FJ; Yeates P; Aram M; Hewson R Vaccine; 2019 Aug; 37(36):5404-5413. PubMed ID: 31331770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]